AB
FENC icon

Amalgamated Bank’s Fennec Pharmaceuticals FENC Stock Holding History

Amalgamated Bank’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-736
Closed -$6K – 2038
2025
Q4 		$6K Sell
736
-85
-10% -$698 ﹤0.01% 2637
2025
Q3 		$8K Hold
821
– – ﹤0.01% 2556
2025
Q2 		$7K Hold
821
– – ﹤0.01% 2585
2025
Q1 		$5K Buy
821
+209
+34% +$1.34K ﹤0.01% 2650
2024
Q4 		$4K Hold
612
– – ﹤0.01% 2783
2024
Q3 		$3K Hold
612
– – ﹤0.01% 2874
2024
Q2 		$4K Hold
612
– – ﹤0.01% 2844
2024
Q1 		$7K Sell
612
-1,224
-67% -$12.3K ﹤0.01% 2573
2023
Q4 		$21K Sell
1,836
-182
-9% -$1.51K ﹤0.01% 2620
2023
Q3 		$15K Hold
2,018
– – ﹤0.01% 2778
2023
Q2 		$18K Buy
+2,018
New +$16.8K ﹤0.01% 2785

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Amalgamated Bank's FENC Position: Q1 2026 in Review

Amalgamated Bank sold out of Fennec Pharmaceuticals (FENC) in Q1 2026, closing a stake of 736 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in FENC in Q2 2023 and held it in 11 quarters. The position peaked at $21K in Q4 2023. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Amalgamated Bank reported no remaining Fennec Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 736 Fennec Pharmaceuticals shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Fennec Pharmaceuticals in Q2 2023 and held it in 11 quarters.
  • Amalgamated Bank's Fennec Pharmaceuticals position peaked at $21K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.